UBS Group AG (UBS) Cash Flow Statement

The consistent positive net income, despite integration costs, suggests the bank is building capital internally. The CET1 ratio remains a key metric to watch, as retained earnings are crucial for meeting Swiss regulatory requirements. The absence of large cash outflows for dividends or buybacks in 2026Q1 further supports capital accumulation.

The consistent pattern of purchasing more securities than selling suggests a strategy to deploy excess liquidity into higher-yielding assets, possibly to offset the low NIM. However, the net cash outflow from these activities may indicate a shift towards shorter-duration or more liquid securities, which could impact future interest income. Investors should monitor the yield on the securities portfolio as rates evolve.

The rise in loan loss provisions, though still modest, indicates that the bank is growing its loan portfolio, likely in the Swiss domestic market. This growth is a positive sign for NII, but it also requires careful monitoring of credit quality, especially given the integration of Credit Suisse's legacy book. The cash flow statement does not directly show loan originations, but the provisioning trend implies continued expansion.

The relatively small buyback and dividend figures, compared to net income, indicate that management is prioritizing capital retention over shareholder returns. This is likely due to the need to build regulatory capital buffers and fund integration costs. As the integration completes, investors may expect an increase in capital returns, but this will depend on regulatory approvals and the final capital requirements.

The cash flow data does not directly show deposit flows, but the absence of large financing outflows suggests that deposits are stable. The Swiss domestic monopoly position likely provides a sticky, low-cost deposit base, which is crucial for funding the loan book and securities portfolio. However, the bank's reliance on wholesale funding, as indicated by the debt/equity ratio of 3.94, warrants monitoring for any shifts in market confidence.